Septerna, Inc. Files 8-K Report
Ticker: SEPN · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1984086
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
Septerna filed an 8-K, likely with financial updates. Watch for details.
AI Summary
On January 13, 2025, Septerna, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This filing indicates Septerna, Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate negative or positive financial implications mentioned.
Key Players & Entities
- Septerna, Inc. (company) — Registrant
- January 13, 2025 (date) — Date of Report
- 250 East Grand Avenue, Suite 65 (address) — Principal Executive Offices
- South San Francisco, CA 94080 (address) — Principal Executive Offices Location
- (650) 338-3533 (phone_number) — Registrant's Telephone Number
FAQ
What specific information is disclosed in the Regulation FD section of this 8-K?
The provided text does not specify the content of the Regulation FD disclosure, only that it is part of the filing.
Are there any financial statements included with this 8-K filing?
Yes, the filing is listed as including 'Financial Statements and Exhibits'.
What is Septerna, Inc.'s primary business according to the filing?
Septerna, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]' according to its Standard Industrial Classification.
When was Septerna, Inc. incorporated?
Septerna, Inc. was incorporated in Delaware.
What is the SEC file number for Septerna, Inc.?
The SEC file number for Septerna, Inc. is 001-42382.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2025-01-13 06:07:13
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share SEPN The Nasdaq
Filing Documents
- d912269d8k.htm (8-K) — 25KB
- d912269dex991.htm (EX-99.1) — 28KB
- g912269ex99_1p10g1.jpg (GRAPHIC) — 269KB
- g912269ex99_1p11g1.jpg (GRAPHIC) — 248KB
- g912269ex99_1p12g1.jpg (GRAPHIC) — 210KB
- g912269ex99_1p13g1.jpg (GRAPHIC) — 415KB
- g912269ex99_1p14g1.jpg (GRAPHIC) — 303KB
- g912269ex99_1p15g1.jpg (GRAPHIC) — 288KB
- g912269ex99_1p16g1.jpg (GRAPHIC) — 234KB
- g912269ex99_1p17g1.jpg (GRAPHIC) — 318KB
- g912269ex99_1p18g1.jpg (GRAPHIC) — 334KB
- g912269ex99_1p19g1.jpg (GRAPHIC) — 294KB
- g912269ex99_1p1g1.jpg (GRAPHIC) — 394KB
- g912269ex99_1p20g1.jpg (GRAPHIC) — 381KB
- g912269ex99_1p21g1.jpg (GRAPHIC) — 274KB
- g912269ex99_1p22g1.jpg (GRAPHIC) — 267KB
- g912269ex99_1p23g1.jpg (GRAPHIC) — 381KB
- g912269ex99_1p24g1.jpg (GRAPHIC) — 289KB
- g912269ex99_1p25g1.jpg (GRAPHIC) — 273KB
- g912269ex99_1p26g1.jpg (GRAPHIC) — 298KB
- g912269ex99_1p2g1.jpg (GRAPHIC) — 446KB
- g912269ex99_1p3g1.jpg (GRAPHIC) — 314KB
- g912269ex99_1p4g1.jpg (GRAPHIC) — 401KB
- g912269ex99_1p5g1.jpg (GRAPHIC) — 325KB
- g912269ex99_1p6g1.jpg (GRAPHIC) — 270KB
- g912269ex99_1p7g1.jpg (GRAPHIC) — 257KB
- g912269ex99_1p8g1.jpg (GRAPHIC) — 309KB
- g912269ex99_1p9g1.jpg (GRAPHIC) — 332KB
- 0001193125-25-004909.txt ( ) — 11387KB
- sepn-20250113.xsd (EX-101.SCH) — 3KB
- sepn-20250113_lab.xml (EX-101.LAB) — 19KB
- sepn-20250113_pre.xml (EX-101.PRE) — 12KB
- d912269d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits 99.1 Corporate Presentation of Septerna, Inc., dated January 2025, furnished herewith. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Septerna, Inc. Date: January 13, 2025 By: /s/ Jeffrey Finer, M.D., Ph.D. Jeffrey Finer, M.D., Ph.D. President and Chief Executive Officer